Banco de Sabadell’s Gilead Sciences GILD Stock Holding History

Banco de Sabadell’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-700	Closed	-$51K	–	86
2021 Q4	$51K	Hold	700	–	–	0.03%	77
2021 Q3	$49K	Buy	+700	New	+$49.2K	0.03%	91
2021 Q1	–	Sell	-11,375	Closed	-$651K	–	329
2020 Q4	$651K	Buy	11,375 +1,125	+11%	+$67.9K	0.07%	178
2020 Q3	$643K	Buy	10,250 +1,425	+16%	+$98.8K	0.07%	207
2020 Q2	$668K	Buy	8,825 +3,400	+63%	+$261K	0.09%	157
2020 Q1	$407K	Sell	5,425 -30,393	-85%	-$2.1M	0.06%	201
2019 Q4	$2.33M	Buy	35,818 +30,993	+642%	+$2.02M	0.31%	88
2019 Q3	$305K	Sell	4,825 -40,356	-89%	-$2.64M	0.04%	240
2019 Q2	$3.05M	Sell	45,181 -24,309	-35%	-$1.6M	0.35%	83
2019 Q1	$4.46M	Buy	69,490 +7,206	+12%	+$479K	0.58%	44
2018 Q4	$3.88M	Buy	62,284 +9,440	+18%	+$660K	0.47%	58
2018 Q3	$4.06M	Sell	52,844 -19,650	-27%	-$1.48M	0.44%	51
2018 Q2	$5.12M	Sell	72,494 -1,913	-3%	-$135K	0.65%	40
2018 Q1	$5.57M	Sell	74,407 -18,934	-20%	-$1.51M	0.67%	33
2017 Q4	$6.69M	Buy	+93,341	New	+$7.09M	0.86%	27

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Banco de Sabadell's GILD Position: Q1 2022 in Review

Banco de Sabadell sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 700 shares — an estimated $51K sold.

Banco de Sabadell first reported a position in GILD in Q4 2017 and held it in 15 quarters. The position peaked at $6.69M in Q4 2017. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Banco de Sabadell reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Banco de Sabadell sold 700 Gilead Sciences shares in Q1 2022, an estimated $51K.
Banco de Sabadell first reported a position in Gilead Sciences in Q4 2017 and held it in 15 quarters.
Banco de Sabadell's Gilead Sciences position peaked at $6.69M in Q4 2017.
1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Banco de Sabadell's 13F filing for Q1 2022, filed 12 May 2022.